Employers may dread a knock on the door from an Occupational Safety and Health investigator, but in many circumstances, the first contact with OSHA is through a letter rather than an in-person ...
On November 2, 2025, the FDA issued a complete response letter (CRL) for Alvotech’s abbreviated Biologics License Application (aBLA) for its proposed Simponi ® (golimumab) biosimilar AVT05. The CRL ...
(RTTNews) - Novo Nordisk said that the US Food and Drug Administration has issued a Complete Response Letter or CRL covering the Biologics License Application for once-weekly basal insulin icodec for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results